A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)

Rummel, Mathias J.Mathias J.RummelJanssens, AnnAnnJanssensMacDonald, DavidDavidMacDonaldKeating, Mary-MargaretMary-MargaretKeatingZaucha, Jan M.Jan M.ZauchaDavis, JaclynJaclynDavisLasher, JanetJanetLasherBabanrao Pisal, ChaitaliChaitaliBabanrao PisalIzquierdo, MiguelMiguelIzquierdoFriedberg, Jonathan W.Jonathan W.Friedberg2022-11-242022-11-242021https://jlupub.ub.uni-giessen.de/handle/jlupub/9724http://dx.doi.org/10.22029/jlupub-9112enNamensnennung - Nicht kommerziell 4.0 Internationalddc:610A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)